Hillstream BioPharma | Investor Presentation Deck | 19 slides · page 10 of 19
The slide uses a structural biology diagram to differentiate the binding mechanism of the company's asset from standard-of-care antibodies.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 image 1/1 paragraph 1/1 title 1/1
Components 4
primary illustration paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.